Session 2: Maximizing the survival benefit through a sequential treatment strategy in locally advanced or metastatic urothelial cancer

Release date: 09-05-2024

Expiration date: 08-05-2025

Opening & Keynote Speech: Second-line and salvage treatment decision-making for unresectable locally advanced or metastatic (LA/m) urothelial cancer (UC)

Philippe Barthélémy, MD, PhD

Philippe Barthélémy, MD, PhD

Institute of Cancer in Strasbourg (ICANS)

Strasbourg, France

  • Opening & Keynote Speech: Second-line and salvage treatment decision-making for unresectable locally advanced or metastatic (LA/m) urothelial cancer (UC)

    Philippe Barthélémy, MD, PhD

  • Case 1: Second-line and salvage treatment options after maintenance immunotherapy & Case 2: Second-line and salvage treatment options after platinum-based chemotherapy

    Kate Smith, MBBS, MRCP, MD, PhD

  • Panel Discussion & Pearls for Practice

    Aristotelis Bamias, MD, PhD